| Lisa K Sessions, MD | |
|
401 S Alabama St Ste 6a, Butte, MT 59701 | |
| (406) 782-2329 | |
| (406) 782-0289 |
| Full Name | Lisa K Sessions |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 401 S Alabama St Ste 6a, Butte, Montana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992786040 | NPI | - | NPPES |
| 1992786040 | Other | MT | NPI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 8404 (Montana) | Primary |
| Entity Name | Community Hospital Of Anaconda |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1205887924 PECOS PAC ID: 8123938974 Enrollment ID: O20030507000045 |
News Archive
Takeda Pharmaceutical Company Limited today announced that it will present Phase 3 data from the TOURMALINE-MM1 ixazomib clinical trial at the 57th American Society of Hematology (ASH) Annual Meeting to be held in Orlando, Florida from December 5 to 8, 2015.
A study at The University of Texas MD Anderson Cancer Center discovered a cellular pathway tied to cancer that may be beneficial in reducing side effects and extending duration of immunotherapy in some patients with hepatocellular carcinoma, the most common form of liver cancer.
A multinational set of seven teams is banding together to develop a drug that may potentially fight many different cancers through an antibody that would work within the body's metabolic system.
Placing a crib, changing table or even a chair next to a window might offer your child a nice view outside or access to fresh air, but be careful - window falls can happen quickly and in some cases, be deadly.
Identification of two new proteins in the Fanconi anemia DNA repair pathway may help explain genetic instability in people with Fanconi anemia and how otherwise healthy people are susceptible to cancer from environmentally triggered DNA damage.
› Verified 6 days ago
| Entity Name | Community Hospital Of Anaconda |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538597703 PECOS PAC ID: 8123938974 Enrollment ID: O20031119000745 |
News Archive
Takeda Pharmaceutical Company Limited today announced that it will present Phase 3 data from the TOURMALINE-MM1 ixazomib clinical trial at the 57th American Society of Hematology (ASH) Annual Meeting to be held in Orlando, Florida from December 5 to 8, 2015.
A study at The University of Texas MD Anderson Cancer Center discovered a cellular pathway tied to cancer that may be beneficial in reducing side effects and extending duration of immunotherapy in some patients with hepatocellular carcinoma, the most common form of liver cancer.
A multinational set of seven teams is banding together to develop a drug that may potentially fight many different cancers through an antibody that would work within the body's metabolic system.
Placing a crib, changing table or even a chair next to a window might offer your child a nice view outside or access to fresh air, but be careful - window falls can happen quickly and in some cases, be deadly.
Identification of two new proteins in the Fanconi anemia DNA repair pathway may help explain genetic instability in people with Fanconi anemia and how otherwise healthy people are susceptible to cancer from environmentally triggered DNA damage.
› Verified 6 days ago
| Entity Name | Scl Health Medical Group-butte Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477869600 PECOS PAC ID: 2466633102 Enrollment ID: O20110301000023 |
News Archive
Takeda Pharmaceutical Company Limited today announced that it will present Phase 3 data from the TOURMALINE-MM1 ixazomib clinical trial at the 57th American Society of Hematology (ASH) Annual Meeting to be held in Orlando, Florida from December 5 to 8, 2015.
A study at The University of Texas MD Anderson Cancer Center discovered a cellular pathway tied to cancer that may be beneficial in reducing side effects and extending duration of immunotherapy in some patients with hepatocellular carcinoma, the most common form of liver cancer.
A multinational set of seven teams is banding together to develop a drug that may potentially fight many different cancers through an antibody that would work within the body's metabolic system.
Placing a crib, changing table or even a chair next to a window might offer your child a nice view outside or access to fresh air, but be careful - window falls can happen quickly and in some cases, be deadly.
Identification of two new proteins in the Fanconi anemia DNA repair pathway may help explain genetic instability in people with Fanconi anemia and how otherwise healthy people are susceptible to cancer from environmentally triggered DNA damage.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lisa K Sessions, MD 401 W Pennsylvania Ave Ste 300, Anaconda, MT 59711-1999 Ph: (406) 563-8500 | Lisa K Sessions, MD 401 S Alabama St Ste 6a, Butte, MT 59701 Ph: (406) 782-2329 |
News Archive
Takeda Pharmaceutical Company Limited today announced that it will present Phase 3 data from the TOURMALINE-MM1 ixazomib clinical trial at the 57th American Society of Hematology (ASH) Annual Meeting to be held in Orlando, Florida from December 5 to 8, 2015.
A study at The University of Texas MD Anderson Cancer Center discovered a cellular pathway tied to cancer that may be beneficial in reducing side effects and extending duration of immunotherapy in some patients with hepatocellular carcinoma, the most common form of liver cancer.
A multinational set of seven teams is banding together to develop a drug that may potentially fight many different cancers through an antibody that would work within the body's metabolic system.
Placing a crib, changing table or even a chair next to a window might offer your child a nice view outside or access to fresh air, but be careful - window falls can happen quickly and in some cases, be deadly.
Identification of two new proteins in the Fanconi anemia DNA repair pathway may help explain genetic instability in people with Fanconi anemia and how otherwise healthy people are susceptible to cancer from environmentally triggered DNA damage.
› Verified 6 days ago
Dr. Anthony Michael Konecny, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 3070 Atherton Ln, Butte, MT 59701 Phone: 406-494-3277 | |
Dr. Stephen E Halvorson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 S Clark St, Butte, MT 59701 Phone: 406-723-2500 | |
Wendy Terese Grace, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 S Clark St, Butte, MT 59701 Phone: 406-723-2500 | |
Jessie Lyn Kautzman, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 401 S Alabama St Ste 6a, Butte, MT 59701 Phone: 406-563-7239 Fax: 406-782-2890 | |
Patrick J Mcgree, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 225 S Clark St, Butte, MT 59701 Phone: 406-782-2239 Fax: 406-782-4634 | |
Dr. Serena Zephyr Brewer, D.O Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 445 Centennial Ave, Butte, MT 59701 Phone: 406-723-4075 | |
Lori Jane Lagerquist, PA-C Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 435 S Crystal St, Suite 200, Butte, MT 59701 Phone: 406-496-3600 Fax: 406-496-3653 |